Management of Acute Respiratory Distress Syndrome and Refractory Hypoxemia. A Multicenter Observational Study
- PMID: 28910146
- DOI: 10.1513/AnnalsATS.201612-1042OC
Management of Acute Respiratory Distress Syndrome and Refractory Hypoxemia. A Multicenter Observational Study
Abstract
Rationale: Clinicians' current practice patterns in the management of acute respiratory distress syndrome (ARDS) and refractory hypoxemia are not well described.
Objectives: To describe mechanical ventilation strategies and treatment adjuncts for adults with ARDS, including refractory hypoxemia.
Methods: This was a prospective cohort study (March 2014-February 2015) of mechanically ventilated adults with moderate-to-severe ARDS requiring an FiO2 of 0.50 or greater in 24 intensive care units.
Results: We enrolled 664 patients: 222 (33%) with moderate and 442 (67%) with severe ARDS. On Study Day 1, mean Vt was 7.5 (SD = 2.1) ml/kg predicted body weight (n = 625); 80% (n = 501) received Vt greater than 6 ml/kg. Mean positive end-expiratory pressure (PEEP) was 10.5 (3.7) cm H2O (n = 653); 568 patients (87%) received PEEP less than 15 cm H2O. Treatment adjuncts were common (n = 440, 66%): neuromuscular blockers (n = 276, 42%), pulmonary vasodilators (n = 118, 18%), prone positioning (n = 67, 10%), extracorporeal life support (n = 29, 4%), and high-frequency oscillatory ventilation (n = 29, 4%). Refractory hypoxemia, defined as PaO2 less than 60 mm Hg on FiO2 of 1.0, occurred in 138 (21%) patients. At onset of refractory hypoxemia, mean Vt was 7.1 (SD = 2.0) ml/kg (n = 124); 95 patients (77%) received Vt greater than 6 ml/kg. Mean PEEP was 12.1 (SD = 4.4) cm H2O (n = 133); 99 patients (74%) received PEEP less than 15 cm H2O. Among patients with refractory hypoxemia, 91% received treatment adjuncts (126/138), with increased use of neuromuscular blockers (n = 87, 63%), pulmonary vasodilators (n = 57, 41%), and prone positioning (n = 32, 23%).
Conclusions: Patients with moderate-to-severe ARDS receive treatment adjuncts frequently, especially with refractory hypoxemia. Paradoxically, therapies with less evidence supporting their use (e.g., pulmonary vasodilators) were over-used, whereas those with more evidence (e.g., prone positioning, neuromuscular blockade) were under-used. Patients received higher Vts and lower PEEP than would be suggested by the evidence.
Keywords: acute respiratory distress syndrome; lung protective ventilation; neuromuscular blocking agents; prone positioning; refractory hypoxemia.
Comment in
-
Refractory Hypoxemia and Acute Respiratory Distress Syndrome Adjunctive Therapies: An Open Question?Ann Am Thorac Soc. 2017 Dec;14(12):1768-1769. doi: 10.1513/AnnalsATS.201707-547ED. Ann Am Thorac Soc. 2017. PMID: 29192824 No abstract available.
Similar articles
-
Management of refractory hypoxemia in ARDS.Minerva Anestesiol. 2013 Oct;79(10):1173-9. Epub 2013 Jul 15. Minerva Anestesiol. 2013. PMID: 23857446 Review.
-
[Acute respiratory distress syndrome].Medicina (B Aires). 2016;76(4):235-41. Medicina (B Aires). 2016. PMID: 27576283 Review. Spanish.
-
Comparison of prone positioning and high-frequency oscillatory ventilation in patients with acute respiratory distress syndrome.Crit Care Med. 2005 Oct;33(10):2162-71. doi: 10.1097/01.ccm.0000181298.05474.2b. Crit Care Med. 2005. PMID: 16215365 Clinical Trial.
-
Management of refractory hypoxemia.Ann Card Anaesth. 2016 Jan-Mar;19(1):89-96. doi: 10.4103/0971-9784.173030. Ann Card Anaesth. 2016. PMID: 26750680 Free PMC article. Review.
-
Beyond Low Tidal Volume Ventilation: Treatment Adjuncts for Severe Respiratory Failure in Acute Respiratory Distress Syndrome.Crit Care Med. 2018 Nov;46(11):1820-1831. doi: 10.1097/CCM.0000000000003406. Crit Care Med. 2018. PMID: 30247273 Free PMC article. Review.
Cited by
-
Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials.Intensive Care Med Exp. 2020 Oct 23;8(1):61. doi: 10.1186/s40635-020-00348-6. Intensive Care Med Exp. 2020. PMID: 33095344 Free PMC article. Review.
-
Comparing Prone Positioning Use in COVID-19 Versus Historic Acute Respiratory Distress Syndrome.Crit Care Explor. 2022 May 13;4(5):e0695. doi: 10.1097/CCE.0000000000000695. eCollection 2022 May. Crit Care Explor. 2022. PMID: 35783548 Free PMC article.
-
Inhaled epoprostenol for management of acute respiratory failure and pulmonary vascular disease.Pulm Pharmacol Ther. 2025 Jun 11;90:102374. doi: 10.1016/j.pupt.2025.102374. Online ahead of print. Pulm Pharmacol Ther. 2025. PMID: 40513981 Review.
-
The Physiological Basis of High-Frequency Oscillatory Ventilation and Current Evidence in Adults and Children: A Narrative Review.Front Physiol. 2022 Apr 26;13:813478. doi: 10.3389/fphys.2022.813478. eCollection 2022. Front Physiol. 2022. PMID: 35557962 Free PMC article. Review.
-
Patients with acute respiratory distress syndrome exhibit increased stromelysin1 activity in the blood samples.Cytokine. 2020 Jul;131:155086. doi: 10.1016/j.cyto.2020.155086. Epub 2020 Apr 6. Cytokine. 2020. PMID: 32272349 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources